J Physiol JP - online manuscript tracking
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Physiol Volume 580, Number 1, 39-49, April 1, 2007 DOI: 10.1113/jphysiol.2006.126391
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
580/1/39    most recent
jphysiol.2006.126391v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vay, L.
Right arrow Articles by Alvarez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vay, L.
Right arrow Articles by Alvarez, J.
Related Collections
Right arrow Cellular

CELLULAR

Modulation of Ca2+ release and Ca2+ oscillations in HeLa cells and fibroblasts by mitochondrial Ca2+ uniporter stimulation

 Laura Vay1, Esther Hernández-SanMiguel1, Jaime Santo-Domingo1, Carmen D. Lobatón1, Alfredo Moreno1, Mayte Montero1 and Javier Alvarez1

1 Instituto de Biología y Genética Molecular (IBGM), Departamento de Bioquímica y Biología Molecular y Fisiología, Facultad de Medicina, Universidad de Valladolid and Consejo Superior de Investigaciones Científicas (CSIC), Ramón y Cajal, 7, E-47005 Valladolid, Spain


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 References
 
The recent availability of activators of the mitochondrial Ca2+ uniporter allows direct testing of the influence of mitochondrial Ca2+ uptake on the overall Ca2+ homeostasis of the cell. We show here that activation of mitochondrial Ca2+ uptake by 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) or kaempferol stimulates histamine-induced Ca2+ release from the endoplasmic reticulum (ER) and that this effect is enhanced if the mitochondrial Na+–Ca2+ exchanger is simultaneously inhibited with CGP37157. This suggests that both Ca2+ uptake and release from mitochondria control the ability of local Ca2+ microdomains to produce feedback inhibition of inositol 1,4,5-trisphosphate receptors (InsP3Rs). In addition, the ability of mitochondria to control Ca2+ release from the ER allows them to modulate cytosolic Ca2+ oscillations. In histamine stimulated HeLa cells and human fibroblasts, both PPT and kaempferol initially stimulated and later inhibited oscillations, although kaempferol usually induced a more prolonged period of stimulation. Both compounds were also able to induce the generation of Ca2+ oscillations in previously silent fibroblasts. Our data suggest that cytosolic Ca2+ oscillations are exquisitely sensitive to the rates of mitochondrial Ca2+ uptake and release, which precisely control the size of the local Ca2+ microdomains around InsP3Rs and thus the ability to produce feedback activation or inhibition of Ca2+ release.

(Received 11 December 2006; accepted after revision 15 January 2007; first published online 18 January 2007)
Corresponding author J. Alvarez: Instituto de Biología y Genética Molecular (IBGM), Departamento de Bioquímica y Biología Molecular y Fisiología, Facultad de Medicina, Ramón y Cajal, 7, E-47005 Valladolid, Spain. Email: jalvarez{at}ibgm.uva.es


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 References
 
Over the last decade, evidence has been growing regarding the participation of mitochondria in the control of global cellular Ca2+ homeostasis. The mitochondrial Ca2+ uptake mechanism has both high rate and low Ca2+ affinity and appears to be specially designed to take up Ca2+ from local microdomains of high [Ca2+], thus controlling their size and magnitude. High Ca2+ microdomains are usually generated in close proximity to open Ca2+ channels, either on the cytosolic side of the plasma membrane (for plasma membrane Ca2+ channels) or on the cytosolic side of the endoplasmic reticulum (ER) (e.g. for inositol 1,4,5-trisphosphate (InsP3) receptors (InsP3Rs)). Mitochondria placed close to these channels may take up large amounts of Ca2+ and thus modulate the amplitude of the microdomain and its physiological function. In fact, we have shown in chromaffin cells that mitochondria are able to take up transiently most of the Ca2+ entering the cells through Ca2+ channels during cell stimulation (Villalobos et al. 2002). Thus, acting as transient Ca2+ buffers, mitochondria can modulate physiological phenomena triggered by cytosolic [Ca2+] ([Ca2+]c), such as secretion (Giovannucci et al. 1999; Montero et al. 2000).

In non-excitable cells, regenerative Ca2+ oscillations and waves can be produced by several mechanisms (for reviews see Putney & Bird, 1993; Fewtrell, 1993; Berridge & Dupont, 1994; Miyakawa et al. 2001; Hattori et al. 2004), but a key element is the dual positive and negative feedback regulation of InsP3Rs by the released Ca2+. Opening of InsP3Rs requires both InsP3 and Ca2+ in the submicromolar range but an increase in the local [Ca2+]c above the micromolar range becomes inhibitory (Bezprozvanny et al. 1991; Kaftan et al. 1997). Thus, mitochondria placed close to InsP3Rs in the ER may be able to control their activity by modulating the [Ca2+]c microenvironment in the cytosolic mouth of the channel. In fact, there is both structural and functional evidence suggesting the presence of specific and stable interactions between mitochondria and ER which facilitate a rapid and nearly direct flux of Ca2+ from ER to mitochondria (Rizzuto et al. 1998; Hajnoczky et al. 1999, 2000; Filippin et al. 2003). These tight ER–mitochondria couplings may also serve to modulate Ca2+ release.

The role of mitochondria in cytosolic Ca2+ signalling has been tested mostly by using protonophores or respiratory chain inhibitors to depolarize the mitochondrial membrane, thus abolishing the driving force for Ca2+ uptake into the organelle. Usually, the [Ca2+]c transient induced by different stimuli is larger when mitochondria are depolarized, confirming that mitochondria take up significant amounts of Ca2+ during cell stimulation (Werth & Thayer, 1994; White & Reynolds, 1997; Babcock et al. 1997; Montero et al. 2001). In addition, mitochondrial depolarization inhibits the production of regenerative oscillations (Collins et al. 2000) and facilitates ER Ca2+ depletion (Arnaudeau et al. 2001; Malli et al. 2003) in histamine-stimulated HeLa cells. On the other hand, we have shown recently that inhibition with CGP37157 of Ca2+ efflux from mitochondria through the mitochondrial Na+–Ca2+ exchanger (MNCE) changes the pattern of oscillations in HeLa cells and produces regenerative oscillations in human fibroblasts (Hernández-SanMiguel et al. 2006). CGP37157 also activated Ca2+ release from the ER (Hernández-SanMiguel et al. 2006) and reduced ER Ca2+ refilling (Arnaudeau et al. 2001; Malli et al. 2005). Thus, MNCE has been implicated in the control of ER Ca2+ release and Ca2+ oscillations (Hernández-SanMiguel et al. 2006), ER–mitochondria Ca2+ recycling (Arnaudeau et al. 2001) and the transfer of Ca2+ from the extracellular medium to the ER through mitochondria (Malli et al. 2003, 2005).

We have taken advantage here of the recent availability of strong activators of the mitochondrial Ca2+ uniporter (MCU; see Montero et al. 2002, 2004; Lobatón et al. 2005) to investigate the role of mitochondrial Ca2+ uptake in the control of ER Ca2+ release and cytosolic Ca2+ oscillations. We show here that these phenomena are highly sensitive to changes in the activity of the MCU, thus providing new evidence for the critical role of mitochondria in the control of global cell Ca2+ homeostasis.


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 References
 
Cell culture and targeted aequorin expression

HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. The constructs for aequorin targeted to the cytosol and mutated aequorin targeted to either the ER or the mitochondria have been previously described (Montero et al. 1995, 2000). Transfections were carried out using Metafectene (Biontex, Munich, Germany). Cultures of human fibroblasts were obtained from skin biopsies of healthy human volunteers. They were grown in 199 medium supplemented with 10% fetal calf serum.

Mitochondrial and ER [Ca2+] measurements in cell populations with targeted aequorin

Mitochondrial [Ca2+] ([Ca2+]m) measurements were made using wild-type HeLa cells transfected with the pcDNA3.1 plasmid containing the construct for mitochondrially targeted mutated aequorin. For aequorin reconstitution, HeLa cells expressing mitochondrially targeted mutated aequorin were incubated for 1–2 h at room temperature (20°C) with 1 µM wild-type coelenterazine in standard medium containing (mM): NaCl 145, KCl 5, MgCl2 1, CaCl2 1, glucose 10 and Hepes 10; pH 7.4. Cells were then placed in the perfusion chamber of a purpose-built luminometer thermostatically controlled at 37°C. ER [Ca2+] ([Ca2+]ER) measurements were carried out using HeLa cells transiently transfected with the plasmid for ER-targeted aequorin. Cells were plated onto 13 mm round coverslips. Before reconstituting aequorin, [Ca2+]ER was reduced by incubating the cells for 10 min at 37°C with the sarcoplasmic reticulum and ER Ca2+-ATPase inhibitor 2,5-di-tert-buthyl-benzohydroquinone (BHQ; 10 µM) in medium containing (mM): NaCl 145, KCl 5, MgCl2 1, glucose 10 and Hepes 10; pH 7.4, supplemented with 0.5 mM EGTA. Cells were then washed and incubated for 1 h at room temperature in the same medium with 1 µM coelenterazine n, a low sensitivity analog of wild type coelenterazine which allows measuring the higher [Ca2+] present in the ER. Then, the coverslip was placed in the perfusion chamber of a purpose-built thermostatically controlled luminometer, and the same medium containing 0.5 mM EGTA was perfused for 5 min prior to the experiment.

Single-cell [Ca2+]c measurements

HeLa cells or fibroblasts were loaded with fura-2 by incubation in standard medium containing 2 µM acetoxymethyl ester form of fura-2- (fura-2-AM) for 45 min at room temperature. Cells were then washed with standard medium for 45 min at room temperature and mounted in a cell chamber on the stage of a Zeiss Axiovert 200 microscope under continuous perfusion. Single-cell fluorescence was excited at 340 nm and 380 nm using a Cairn monochromator (100 ms excitation at each wavelength every 2 s, 10 nm bandwidth) and images of the emitted fluorescence obtained with a 40 x Fluar objective were collected using a 400DCLP dichroic mirror and a D510/80 emission filter (both from Chroma Technology) and recorded with a Hamamatsu ORCA-ER camera. Single-cell fluorescence was recorded as 340/380 nm fluorescence ratio and calibrated into [Ca2+] values off-line as previously described (Grynkiewicz et al. 1985) using the Metafluor program (Universal Imaging). Experiments were performed at 37°C using an on-line heater from Harvard Apparatus.

Materials

Wild-type coelenterazine, coelenterazine n and fura-2-AM were obtained from Molecular Probes, OR, USA. CGP37157, PPT and kaempferol were from Tocris, Bristol, UK. Other reagents were from Sigma, Madrid or Merck, Darmstadt.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 References
 
We have shown before that the synthetic oestrogen agonist PPT is a potent activator of Ca2+ uptake into mitochondria both in intact and permeabilized cells (Lobatón et al. 2005). PPT largely increased (up to 6-fold) the [Ca2+]m peak induced by histamine in HeLa cells (Lobatón et al. 2005), an effect that was not secondary to an increased Ca2+ release from the ER, as the [Ca2+]c peak induced by histamine was in fact slightly reduced in the presence of PPT (by about 20%). However, we did not explore further the effects of PPT on ER Ca2+ release and [Ca2+]c dynamics. We have recently described that inhibiting mitochondrial Ca2+ release with CGP37157 activates Ca2+ release from the ER (Hernández-SanMiguel et al. 2006) and promotes the production of regenerative cytosolic Ca2+ oscillations in HeLa cells and fibroblasts. Figure 1A shows that activation of the MCU with PPT also enhanced histamine-induced Ca2+ release form the ER and that the effect was dose-dependent within the same range of concentrations required to activate the MCU. In addition, Fig. 1B shows that CGP37157 potentiated the activation of ER Ca2+ release induced by PPT, suggesting that both activation of mitochondrial Ca2+ uptake and inhibition of mitochondrial Ca2+ release cooperate to activate Ca2+ release from the ER.


Figure 1
View larger version (34K):
[in this window]
[in a new window]

  		Figure 1.  Effects of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), kaempferol and CGP37157 on histamine-induced Ca2+ release from the ER
HeLa cells expressing endoplasmic reticulum (ER)-targeted mutated aequorin were reconstituted with coelenterazine n in 0.5 mM EGTA-containing medium as described in the Methods. As indicated, 1 mM Ca2+-containing standard medium was perfused to refill the ER with Ca2+. Cells were then stimulated with histamine (100 µM or 5 µM) either under control conditions or in the presence of PPT, CGP37157 or kaempferol at the concentrations indicated (micromolar). These compounds were also present in the Ca2+-containing medium used to refill the ER in A, B and D, and were added when indicated (drug) in C. In B, drug concentrations were: PPT, 2 µM; CGP37157, 10 µM. Experiments shown in C were performed at 22°C, and the rest at 37°C. In A and B, the traces shown are the mean of two experiments of each type and they are representative of 10–12 similar experiments of each type. The traces shown in C are the mean of three experiments of each kind. The traces shown in D are each the mean of 15 experiments.

 
As we have reported previously (Montero et al. 1997; see Fig. 1), Ca2+ release induced by histamine in these cells is biphasic. It starts with a very fast initial drop of [Ca2+]ER lasting for about 10 s that suddenly stops and is followed by a slower phase of release which continues as long as histamine is present. The first phase is responsible for the peak of [Ca2+]c and the second one keeps [Ca2+]c in at an elevated level while histamine is present. It is worth mentioning here that the large increase in mitochondrial Ca2+ uptake induced by PPT led to a decrease in the histamine-induced [Ca2+]c peak (Lobatón et al. 2005), in spite of the fact that PPT enhanced both phases of Ca2+ release. In a series of experiments similar to those shown in Fig. 1, the percentage decrease in [Ca2+]ER during the fast phase was (mean ± S.E.M.): controls, 17.2 ± 1.2% (n = 16); 2 µM PPT, 25.3 ± 1.5% (n = 16); 5 µM PPT, 34.5 ± 2.5% (n = 7); 2 µM PPT + 10 µM CGP37157, 33.7 ± 2.8% (n = 7) and the total Ca2+ released in both phases, measured 3 min after histamine addition, was (mean ± S.E.M.): controls, 40.3 ± 2.8% (n = 16); 2 µM PPT, 59.8 ± 2.6% (n = 16); 5 µM PPT, 75.5 ± 2.5% (n = 7); 2 µM PPT + 10 µM CGP37157, 71.6 ± 3.3% (n = 7). Therefore, in the presence of 2 µM PPT, the amount of Ca2+ released by the ER in response to histamine increased by about 50% in both phases, and in the presence of 5 µM PPT it increased almost 2-fold. Given that the [Ca2+]c peak obtained was smaller than in the control, this implies that all the additional Ca2+ released in the presence of the MCU activator was taken up by mitochondria. In the experiments shown in Fig. 1A and B, the agonist was added before the ER was fully refilled with Ca2+. The reason for adding histamine so early is the fast consumption of aequorin at the high [Ca2+] reached in the ER, which means that [Ca2+]ER can only be measured for a few minutes (Alvarez & Montero, 2002). To be sure that the effects of PPT also occurred when [Ca2+]ER was at steady state, we performed similar experiments at a lower temperature. We have previously described that reducing the temperature to 22°C reduces the rate of light emission of aequorin, so that longer records of [Ca2+]ER can be obtained (Barrero et al. 1997; Alvarez & Montero, 2002). Figure 1C shows that PPT also produced an increase in the rate of Ca2+ release from the ER under steady-state [Ca2+]ER. This figure also shows that the flavonoid kaempferol, which is also a potent activator of the mitochondrial Ca2+ uniporter (Montero et al. 2004) but has a completely different chemical structure, similarly activates Ca2+ release from the ER. In addition, this figure shows that application of PPT or kaempferol alone produces no change in [Ca2+]ER.

If PPT activates InsP3-induced Ca2+ release, we reasoned that it could also modify the dynamics of cytosolic Ca2+ oscillations, as occurs with CGP37157 (Hernández-SanMiguel et al. 2006). That was the case, although the effect of PPT was different from that of CGP37157. In the single-cell experiments, we stimulated HeLa cells initially with 100 µM histamine and then a lower histamine concentration (3–5 µM) was maintained in order to reduce the frequency and facilitate the generation of long-lasting oscillations. Figure 1D shows the effect of this protocol on Ca2+ release from the ER. When histamine was reduced from 100 to 5 µM, [Ca2+]ER increased both in the presence and in the absence of PPT, but remained lower in the presence of PPT compared with the controls. Figure 2A shows that in HeLa cells, histamine-induced Ca2+ oscillations progressively decreased in frequency and amplitude after perfusion of PPT and finally stopped. This behaviour was observed in 87% of the cells (358 of 412 analysed cells), while either no effect or an increase in frequency was observed in the rest. Reversion of this effect was very slow and was observed only in some cells (17%, 40 of 234 cells in which recovery was measured). Figure 2B shows data from an experiment in which oscillations reappeared in several cells about 10 min after PPT was washed out. It is interesting to note that in many cells, the blocking effect of PPT was preceded by a transient increase in the magnitude or width of the oscillations, suggesting that an increase in Ca2+ release was the primary effect of PPT. In fact, in experiments where cells had low-amplitude or irregular oscillations, PPT addition generated a transient burst of oscillations (Fig. 2C).


Figure 2
View larger version (46K):
[in this window]
[in a new window]

  		Figure 2.  Effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) on histamine-induced Ca2+ oscillations
Fura-2-loaded HeLa cells incubated in 1 mM Ca2+-containing standard medium were stimulated with histamine and treated with PPT as indicated. A–C, show single-cell Ca2+ records from three different experiments. Traces of four representative single cells present in the same microscope field for each experiment are shown. The bottom traces show the mean of all the cells analysed in each experiment (20, 29 and 31 cells for A, B and C, respectively; note the enhanced scale). The initial histamine-stimulated [Ca2+]c peaks are truncated for convenience. Data are representative of 412 analysed cells.

 
Similar findings were obtained in histamine-stimulated HeLa cells treated with CGP37157 to induce the generation of baseline spike oscillations. Figure 3 shows that, as previously shown (Hernández-SanMiguel et al. 2006), addition of CGP37157 changed the pattern of the Ca2+ oscillations, particularly in those cells showing a more irregular pattern beforehand. Then, subsequent perfusion of PPT decreased again both frequency and amplitude of the oscillations, leading to a complete cessation after 5–10 min. This behaviour was observed in 95% of the cells (307 of 322 analysed cells). Again here, PPT induced in some cells a burst of oscillations before blocking them (see second trace from top and also the bottom trace, which shows the mean response of the 29 cells present in the same microscope field). Reversion of the blocking effect of PPT (as shown in Fig. 3) was observed only in some cells (12%, 31 of 261 cells in which recovery was assayed) and was also quite slow, requiring a washout period of at least 10–20 min. The reason for this slow recovery of the oscillatory behaviour is probably the slow reversion of the effect of PPT. Table 1 shows the rate of disappearance of the effect of PPT on the histamine-induced [Ca2+]m peak. In the presence of 2 µM PPT, the [Ca2+]m peak increased about 3-fold over the control values. Washing out PPT then reduced its effect slowly, so that after 10 min washout, the [Ca2+]m peak was still about 50% higher than in the controls. Similar findings were originally reported for SB202190 (Montero et al. 2002).


Figure 3
View larger version (42K):
[in this window]
[in a new window]

  		Figure 3.  Effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) on histamine-induced Ca2+ oscillations in the presence of CGP37157
Fura-2-loaded HeLa cells incubated in 1 mM Ca2+-containing standard medium were stimulated with histamine and treated with 10 µM CGP37157 and 2 µM PPT as indicated. The bottom trace shows the mean of all the cells analysed in the experiment (29 cells). Data are representative of 322 analysed cells.

 

View this table:
[in this window]
[in a new window]

  		Table 1.  Rate of reversal of the effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) on the histamine-induced mitochondrial [Ca2+] ([Ca2+]m) peak
 
To obtain further evidence that the effects of PPT were due to stimulation of MCU, we have also studied the effects of kaempferol on Ca2+ oscillations. As mentioned above, this compound is a flavonoid with a chemical structure completely different from that of PPT, but it is also a potent activator of MCU (Montero et al. 2004). We showed in Fig. 1C that it produced the same effects as PPT on histamine-induced Ca2+ release from the ER. Now we show in Fig. 4 its effects on Ca2+ oscillations. We have used a concentration (10 µM) that produces an activation of MCU similar to that induced by 2 µM PPT. As we have shown before (Montero et al. 2004; Lobatón et al. 2005), both 2 µM PPT and 7 µM kaempferol increased by 10-fold the rate of Ca2+ uptake by mitochondria. Addition of kaempferol always produced an initial burst of activity, similar to that induced by PPT although usually more prolonged. That initial burst was followed by a series of oscillations with progressively smaller amplitude and in most cases the oscillatory behaviour final ceased. Figure 4A shows two typical experiments in which kaempferol induced a more or less prolonged burst of oscillations. The bottom traces, which correspond to the mean behaviour of all the cells present in the same microscope field, show that most of the cells responded in the same way.


Figure 4
View larger version (42K):
[in this window]
[in a new window]

  		Figure 4.  Effect of kaempferol on histamine-induced Ca2+ oscillations
Fura-2-loaded HeLa cells incubated in 1 mM Ca2+-containing standard medium were stimulated with histamine and treated with 10 µM kaempferol as indicated. Traces of four representative single cells present in the same microscope field for each experiment are shown. The bottom traces show the mean of all the cells analysed in each experiment (32 and 40 cells for A and B, respectively). Data are representative of 352 cells treated with the same protocol.

 
We next investigated the behaviour of [Ca2+]m in the presence of cytostolic Ca2+ oscillations and one or more of these compounds (experiments similar to those shown in Figs 2 and 3). Figure 5 shows the effects of PPT, kaempferol and CGP37157 on [Ca2+]m under similar conditions to those used in Figs 2–4. Measurements were performed in cell populations expressing mitochondrially targeted mutated aequorin (Montero et al. 2002). HeLa cells were stimulated with histamine, and then either PPT, kaempferol, CGP37157 or the combination of CGP37157 and one of the two MCU activators was applied. As we have previously described, inhibition of MNCE with CGP37157 produced a small and slow increase in the mean [Ca2+]m within the submicromolar range (Hernández-SanMiguel et al. 2006). Instead, stimulation of the MCU with PPT did not produce by itself any significant change in the mean [Ca2+]m, but strongly potentiated the effect of CGP37157. In the case of kaempferol, it produced a small increase in [Ca2+]m by itself, which was also enhanced by CGP37157. The mean increase in [Ca2+]m observed 5 min after the addition of each drug in experiments similar to those of Fig. 5 was (mean ± S.E.M.): 2 µM PPT alone, 0.02 ± 0.01 µM (n = 22); 10 µM kaempferol alone, 0.28 ± 0.03 (n = 16); 10 µM CGP alone, 0.20 ± 0.04 µM (n = 25); 2 µM PPT + 10 µM CGP37157, 0.79 ± 0.13 µM (n = 26); 10 µM kaempferol + 10 µM CGP37157, 0.54 ± 0.03 (n = 16).


Figure 5
View larger version (27K):
[in this window]
[in a new window]

  		Figure 5.  Effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), CGP37157, kaempferol, and the combinations of PPT + CGP37157 and kaempferol + CGP37157 on [Ca2+]m in histamine-stimulated HeLa cells
HeLa cells expressing mitochondrially targeted mutated aequorin were reconstituted with native coelenterazine, stimulated for 1 min with 100 µM histamine and then perfused with medium containing 5 µM histamine and either 2 µM PPT, 10 µM CGP37157, 10 µM kaempferol or the drug combinations as indicated. All perfusion media contained 1 mM Ca2+. Mean values for the effect of each drug on [Ca2+]m are given in the text.

 
We then investigated the effect of stimulating MCU on Ca2+ oscillations in human fibroblasts. Figure 6 shows that in human fibroblasts stimulated with CGP37157 to produce oscillations, PPT induced similar effects to those observed in HeLa cells; that is, a decrease in frequency or cessation of the oscillatory behaviour. This kind of effect was observed in most (95%, 61 of 64 analysed cells) of the cells exposed to this experimental protocol. Reversion of this PPT block, which was only observed in some of the cells (41%, 11 of 27 cells in which recovery was assayed), again required a prolonged (~10 min) washout period for PPT. However, in the absence of CGP37157, the response of [Ca2+]c dynamics to PPT perfusion was more diverse. In about half of the cells (52%, 121 of 231 analysed cells), the response was again similar to that observed in HeLa cells; that is, an initial stimulation followed by inhibition of the oscillations. Figure 7A shows an experiment in which PPT stopped the spontaneous oscillations almost completely within a few minutes, an effect that was usually not reversible. In other cells, instead, PPT increased the frequency of the oscillations (11%, 25 of 231 analysed cells, see Fig. 7B), induced the generation of oscillations in cells that were previously silent (28%, 65 of 231 analysed cells, see Fig. 7C) or had no effect (9%, 20 of 231 analysed cells). Stimulation or generation of Ca2+ oscillations was even more frequent when kaempferol was used to stimulate MCU. This flavonoid increased the frequency or amplitude of the oscillations in all the cells tested having spontaneous oscillations (100%, 32 of 32) and induced the generation of oscillations in about half of the cells (47%, 49 of 105 analysed cells) that were silent under resting conditions. Figure 8A shows single-cell traces representative of these two behaviours. However, in the presence of CGP37157, kaempferol predominantly inhibited oscillations after an initial burst of activity (51%, 26 of 51 analysed cells), although either no effect (20%, 10 of 51 analysed cells) or a persistent stimulation of the oscillatory behaviour (29%, 15 of 51 analysed cells) was also observed. Figure 8B shows representative single-cell traces.


Figure 6
View larger version (31K):
[in this window]
[in a new window]

  		Figure 6.  Effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) on Ca2+ oscillations stimulated with CGP37157 in human fibroblasts
Fura-2-loaded human fibroblasts incubated in 1 mM Ca2+-containing medium were treated with 10 µM CGP37157 and 2 µM PPT as indicated. Traces correspond to four cells present in the same microscope field in one experiment (of a total of six cells analysed).

 

Figure 7
View larger version (32K):
[in this window]
[in a new window]

  		Figure 7.  Effect of 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) on spontaneous Ca2+ oscillations in human fibroblasts
Fura-2-loaded human fibroblasts incubated in 1 mM Ca2+-containing medium were treated with 2 µM PPT as indicated. A–C, show data from three different experiments. The bottom trace in A shows the mean of all the cells analysed in that experiment (13 cells).

 

Figure 8
View larger version (37K):
[in this window]
[in a new window]

  		Figure 8.  Effect of kaempferol on spontaneous and CGP37157-induced Ca2+ oscillations in human fibroblasts
Fura-2-loaded human fibroblasts incubated in 1 mM Ca2+-containing medium were treated with 10 µM CGP37157 and/or 10 µM kaempferol, as indicated. Representative single-cell traces for each protocol are shown.

 

   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
References
 
We show in this paper new evidence that mitochondrial Ca2+ uptake modulates [Ca2+] dynamics in the cytosol. We have used two activators of MCU, recently described by us, to show that the rate of Ca2+ uptake by mitochondria controls Ca2+ release from the ER and cytosolic Ca2+ oscillations. The two compounds, the synthetic oestrogen receptor agonist PPT and the flavonoid kaempferol, have completely different molecular structures, but they similarly activate MCU (Montero et al. 2004; Lobatón et al. 2005) and we show here that they also both activate Ca2+ release from the ER. Regarding Ca2+ oscillations, the modulation appears to be quite subtle – a sort of fine tuning – as activation of MCU may trigger both activation and inhibition of the oscillatory behaviour, even in the same type of cells. In HeLa cells, where Ca2+ oscillations are induced by histamine, activation of MCU produced in most of the cells an initial stimulation followed by inhibition of the oscillations. This effect developed slowly, within 2–5 min of perfusion of the activator, and was also slowly reversible. Both MCU activators (PPT and kaempferol) behaved similarly, although the initial period of stimulation was more prolonged in the presence of kaempferol.

In human fibroblasts, cells undergoing spontaneous Ca2+ oscillations and silent cells coexist under resting conditions. In these cells, the effects of PPT and kaempferol were more diverse. In many of the silent cells, PPT and particularly kaempferol induced the generation of Ca2+ oscillations. However, in cells showing spontaneous oscillations, both compounds behaved differently. PPT abolished or reduced the frequency of the oscillations in most of them, although in a small number (11%) the opposite effect was seen: an increase in the frequency of the oscillations. Instead, kaempferol increased the frequency of the oscillations in all the cells tested. On the other hand, in cells stimulated to oscillate with CGP37157, both PPT and kaempferol inhibited oscillations in most of them, although kaempferol was again able to induce a prolonged stimulation in some cells. In summary, both compounds stimulate Ca2+ release from the ER and produce an initial increase of the oscillatory activity. The duration of such increased activity apparently depends on the compound used (more prolonged stimulation with kaempferol) or on the previous activity of the cell (more prolonged stimulation in cells previously silent compared with active cells or cells stimulated to oscillate with CGP37157).

The reason for the different effect of MCU activation in active or silent fibroblasts may be due to the fact that excess activation of Ca2+ release may lead to ER Ca2+ depletion and feedback inhibition of Ca2+ release induced by the ER Ca2+ depletion. It is known that InsP3Rs are regulated by the level of luminal [Ca2+] (Camacho & Lechleiter, 1995; Caroppo et al. 2003; Higo et al. 2005) and depletion of [Ca2+]ER below certain levels may lead to a prolonged inhibition of the oscillatory activity. Most of the cells in which MCU activation abolished oscillations showed a short burst of activity beforehand (see Figs 2–4 and 6–8). By contrast, in silent cells, the activation of Ca2+ release induced by MCU activators may be just enough to induce them to oscillate.

The mechanism of the effects of MCU activation on Ca2+ release is probably related to the regulation of InsP3Rs by the local [Ca2+] surrounding the cytosolic mouth of the channel. It has been known for many years that InsP3Rs are under a biphasic regulation by the local [Ca2+]c, with submicromolar [Ca2+] being required for activation and supramicromolar [Ca2+] causing inhibition (Bezprozvanny et al. 1991; Kaftan et al. 1997; Miyakawa et al. 2001). This positive and negative feedback regulation appears to be a key element responsible of the production of regenerative Ca2+ oscillations (Putney & Bird, 1993; Fewtrell, 1993; Berridge & Dupont, 1994; Miyakawa et al. 2001; Hattori et al. 2004; Patterson et al. 2004) and mitochondria have been shown before to modulate InsP3-induced Ca2+ release by acting on this mechanism. In hepatocytes, block of mitochondrial Ca2+ uptake increased Ca2+ release, suggesting that mitochondria were suppressing the local feedback activation by Ca2+ of InsP3Rs (Hajnoczky et al. 1999). In HeLa cells, instead, block of mitochondrial Ca2+ uptake with uncouplers inhibited histamine-induced Ca2+ release and oscillations (Collins et al. 2000), perhaps because of the increased feedback inhibition by Ca2+ of InsP3Rs in the absence of Ca2+ uptake by nearby mitochondria. In fact, feedback inhibition by Ca2+ in these cells is the main mechanism limiting histamine-induced Ca2+ release, as histamine induces a fast and complete Ca2+ release from the ER in cells loaded with BAPTA (Montero et al. 1997). The effect of MCU activation increasing ER Ca2+ release in HeLa cells (Fig. 1) is therefore best explained as a result of the reduced feedback inhibition by Ca2+ of InsP3R following the increase in mitochondrial Ca2+ uptake. It is interesting to note that MCU activation produced little increase in the mean [Ca2+]m, except when MNCE was simultaneously inhibited (Fig. 5). This suggests that MNCE rapidly extrudes the increased Ca2+ intake in the presence of the activators, so that the mean [Ca2+]m is little changed. However, if MNCE is inhibited, the increased mitochondrial Ca2+ uptake that is induced by PPT during Ca2+ oscillations, accumulates and results in a much larger mean [Ca2+]m.

Our data therefore suggest that MCU activation potentiates histamine-induced Ca2+ release from the ER by reducing feedback inhibition of InsP3Rs by Ca2+. This is consistent with the reported inhibition of ER Ca2+ release after block of mitochondrial Ca2+ uptake with uncouplers in HeLa cells (Collins et al. 2000). Evidence for the direct interaction between mitochondria and ER has been obtained before from the observation of close physical contacts between both organelles and from the observation that mitochondria take up Ca2+ much more effectively after InsP3-induced Ca2+ release than after global homogeneous increases in [Ca2+] (Rizzuto et al. 1998; Csordas et al. 1999). In addition, there is also evidence that these close couplings between mitochondria and ER facilitate Ca2+ transfer from mitochondria to the ER via MNCE releasing Ca2+ close to ER Ca2+ pumps (Arnaudeau et al. 2001; Malli et al. 2003, 2005). In a similar way, we have recently shown that inhibition of MNCE potentiates Ca2+ release from the ER (Hernández-SanMiguel et al. 2006). This suggested that MNCEs are placed close to InsP3Rs, so that Ca2+ release from mitochondria through this system would be able to generate or maintain the local [Ca2+]c microdomain around InsP3Rs necessary to produce feedback inhibition. Our data here suggest that MCUs are also able to modulate that local [Ca2+]c microdomain and should therefore also be close to InsP3Rs. In fact, we have shown that both MCU activation and MNCE inhibition produce additive effects in terms of activating Ca2+ release (Fig. 1B). It is interesting to note, however, that MNCE inhibition and MCU activation do not produce additive effects on Ca2+ oscillations. Instead, MNCE inhibition enhances oscillations and subsequent MCU activation inhibits them, usually after an initial burst. The most probable explanation for this apparent paradox is the excessive Ca2+ depletion induced by the over-stimulation of Ca2+ release (see Fig. 1), which may preclude further spiking. Both MNCE inhibition and MCU activation would cooperate to reduce the local Ca2+ accumulation around InsP3Rs, thus avoiding feedback Ca2+ inhibition of Ca2+ release and leading to prolonged stimulation of Ca2+ release. In conclusion, our data suggest that InsP3Rs from the ER and MNCEs and MCUs from mitochondria colocalize in the small subcellular regions where ER and mitochondria form close contacts. In these functional units both MCUs and MNCEs finely tune the local [Ca2+]c microdomain to modulate ER Ca2+ release. Figure 9 shows a schematic model of these interactions, which also includes the recycling of Ca2+ through the plasma membrane which is required to maintain oscillations. When cells are activated, InsP3 activates Ca2+ release from the ER until feedback Ca2+ inhibition of InsP3R develops. Then, the [Ca2+]c transient is terminated by the action of plasma membrane and ER Ca2+ pumps and the ER is refilled with Ca2+ entering the cell through plasma membrane store-operated Ca2+ channels. Once the ER is again full of Ca2+ and [Ca2+]c has returned close to resting levels, a new oscillation may appear if InsP3 is still present. As we have shown in this paper, and previously (Hernández-SanMiguel et al. 2006), the balance between the rates of Ca2+ uptake and release from mitochondria modulates feedback Ca2+ inhibition and thus oscillations. In addition, other parameters of the model may also modulate oscillations. It has been shown before that changes in extracellular [Ca2+], and thus changes in Ca2+ entry rate, also affect the frequency of the oscillations (Bootman et al. 1996). We should also mention here that ryanodine receptors, although scarcely present in HeLa cells (Bennett et al. 1996), are also sensitive to local cytosolic Ca2+ levels and their interaction with mitochondria may play a role in the modulation of Ca2+ oscillations in these and other cells. Therefore, the Ca2+ spike frequency appears to be finely modulated by most of the Ca2+ fluxes shown in the model of Fig. 9.


Figure 9
View larger version (45K):
[in this window]
[in a new window]

  		Figure 9.  A putative model of the local interactions between mitochondrial Ca2+ uniporter (MCU), mitochondrial Na+–Ca2+ exchanger (MNCE) and endoplasmic reticulum inositol 1,4,5-trisphosphate receptor (InsP3R)
Ca2+ released through InsP3R is rapidly transported into mitochondria via MCU and then extruded from this organelle through MNCE. 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) activates MCU and CGP37157 inhibits MNCE, so in the presence of both drugs, Ca2+ is accumulated into mitochondria thus reducing the size of the local cytosolic [Ca2+] microdomain around InsP3R. The plasma membrane (PMCA) and endoplasmic reticulum (ER) Ca2+ pumps (SERCA) restore cytosolic and ER [Ca2+] to resting levels in the intervals between oscillations. For this, Ca2+ entry through store-operated channels (SOCs) is also essential. ERM, ER membrane; MOM, mitochondrial outer membrane; MIM, mitochondrial inner membrane; PM plasma membrane.

 


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Alvarez J & Montero M (2002). Measuring [Ca2+] in the endoplasmic reticulum with aequorin. Cell Calcium 32, 251–260.[CrossRef][Medline]

Arnaudeau S, Kelley WL, Walsh JV Jr & Demaurex N (2001). Mitochondria recycle Ca2+ to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions. J Biol Chem 276, 29430–29439.[Abstract/Free Full Text]

Babcock DF, Herrington J, Goodwin PC, Park Y-B & Hille B (1997). Mitochondrial participation in the intracellular Ca2+ network. J Cell Biol 136, 833–843.[Abstract/Free Full Text]

Barrero MJ, Montero M & Alvarez J (1997). Dynamics of [Ca2+] in the endoplasmic reticulum and cytoplasm of intact HeLa cells. J Biol Chem 272, 27694–27699.[Abstract/Free Full Text]

Bennett DL, Cheek TR, Berridge MJ, De Smedt H, Parys JB, Missiaen L & Bootman MD (1996). Expression and function of ryanodine receptors in nonexcitable cells. J Biol Chem 271, 6356–6362.[Abstract/Free Full Text]

Berridge MJ & Dupont G (1994). Spatial and temporal signalling by calcium. Curr Opin Cell Biol 6, 267–274.[CrossRef][Medline]

Bezprozvanny I, Watras J & Ehrlich BE (1991). Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351, 751–754.[CrossRef][Medline]

Bootman MD, Young KW, Young JM, Moreton RB & Berridge MJ (1996). Extracellular calcium concentration controls the frequency of intracellular calcium spiking independently of insotol 1,4,5-trisphosphate production in HeLa cells. Biochem J 314, 347–354.[Medline]

Camacho P & Lechleiter JD (1995). Calreticulin inhibits repetitive intracellular Ca2+ waves. Cell 82, 765–771.[CrossRef][Medline]

Caroppo R, Colella M, Colasuonno A, DeLuisi A, Debellis L, Curci S & Hofer AM (2003). A reassessment of the effects of luminal [Ca2+] on inositol 1,4,5-trisphosphate-induced Ca2+ release from internal stores. J Biol Chem 278, 39503–39508.[Abstract/Free Full Text]

Collins TJ, Lipp P, Berridge MJ, Li W & Bootman MD (2000). Inositol 1,4,5-trisphosphate-induced Ca2+ release is inhibited by mitochondrial depolarization. Biochem J 347, 593–600.[CrossRef][Medline]

Csordas G, Thomas AP & Hajnoczky G (1999). Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J 18, 96–108.[CrossRef][Medline]

Fewtrell C (1993). Ca2+ oscillations in non-excitable cells. Annu Rev Physiol 55, 427–454.[CrossRef][Medline]

Filippin L, Magalhaes PJ, Di Benedetto G, Colella M & Pozzan T (2003). Stable interactions between mitochondria and endoplasmic reticulum allow rapid accumulation of calcium in a subpopulation of mitochondria. J Biol Chem 278, 39224–39234.[Abstract/Free Full Text]

Giovannucci DR, Hlubek MD & Stuenkel EL (1999). Mitochondria regulate the Ca2+-exocytosis relationship of bovine adrenal chromaffin cells. J Neurosci 19, 9261–9270.[Abstract/Free Full Text]

Grynkiewicz G, Poenie M & Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440–3450.[Abstract/Free Full Text]

Hajnoczky G, Csordas G, Madesh M & Pacher P (2000). The machinery of local Ca2+ signalling between sarco-endoplasmic reticulum and mitochondria. J Physiol 529, 69–81.[Abstract/Free Full Text]

Hajnoczky G, Hager R & Thomas AP (1999). Mitochondria suppress local feedback activation of inositol 1,4,5-trisphosphate receptors by Ca2+. J Biol Chem 274, 14157–14162.[Abstract/Free Full Text]

Hattori M, Suzuki AZ, Higo T, Miyauchi H, Michikawa T, Nakamura T, Inoue T & Mikoshiba K (2004). Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. J Biol Chem 279, 11967–11975.[Abstract/Free Full Text]

Hernández-SanMiguel E, Vay L, Santo-Domingo J, Lobatón CD, Moreno A, Montero M & Alvarez J (2006). The mitochondrial Na+/Ca2+ exchanger plays a key role in the control of cytosolic Ca2+ oscillations. Cell Calcium 40, 53–61.[CrossRef][Medline]

Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T & Mikoshiba K (2005). Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120, 85–98.[CrossRef][Medline]

Kaftan EJ, Ehrlich BE & Watras J (1997). Inositol 1,4,5-trisphosphate (InsP3) and calcium interact to increase the dynamic range of InsP3 receptor-dependent calcium signalling. J Gen Physiol 110, 529–538.[Abstract/Free Full Text]

Lobatón CD, Vay L, Hernández-SanMiguel E, SantoDomingo J, Moreno A, Montero M & Alvarez J (2005). Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 145, 862–871.[CrossRef][Medline]

Malli R, Frieden M, Osibow K, Zoratti C, Mayer M, Demaurex N & Graier WF (2003). Sustained Ca2+ transfer across mitochondria is essential for mitochondrial Ca2+ buffering, store-operated Ca2+ entry, and Ca2+ store refilling. J Biol Chem 278, 44769–44779.[Abstract/Free Full Text]

Malli R, Frieden M, Trenker M & Graier WF (2005). The role of mitochondria for Ca2+ refilling of the endoplasmic reticulum. J Biol Chem 280, 12114–12122.[Abstract/Free Full Text]

Miyakawa T, Mizushima A, Hirose K, Yamazawa T, Bezprozvanny I, Kurosaki T & Iino M (2001). Ca2+-sensor region of IP3 receptor controls intracellular Ca2+ signaling. EMBO J 20, 1674–1680.[CrossRef][Medline]

Montero M, Alonso MT, Albillos A, García-Sancho J & Alvarez J (2001). Mitochondrial Ca2+-induced Ca2+ release mediated by the Ca2+ uniporter. Mol Biol Cell 12, 63–71.[Abstract/Free Full Text]

Montero M, Alonso MT, Carnicero E, Cuchillo-Ibañez I, Albillos A, Garcia AG, Garcia-Sancho J & Alvarez J (2000). Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca2+ transients that modulate secretion. Nat Cell Biol 2, 57–61.[CrossRef][Medline]

Montero M, Barrero MJ & Alvarez J (1997). [Ca2+] microdomains control agonist-induced Ca2+ release in intact HeLa cells. FASEB J 11, 881–885.[Abstract]

Montero M, Brini M, Marsault R, Alvarez J, Sitia R, Pozzan T & Rizzuto R (1995). Monitoring dynamic changes in free Ca2+ concentration in the endoplasmic reticulum of intact cells. EMBO J 14, 5467–5475.[Medline]

Montero M, Lobatón CD, Hernández-SanMiguel E, Santo-Domingo J, Vay L, Moreno A & Alvarez J (2004). Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids. Biochem J 384, 19–24.[CrossRef][Medline]

Montero M, Lobatón CD, Moreno A & Alvarez J (2002). A novel regulatory mechanism of the mitochondrial Ca2+ uniporter revealed by the p38 mitogen-activated protein kinase inhibitor SB202190. FASEB J 16, 1955–1957.[Abstract/Free Full Text]

Patterson RL, Boehning D & Snyder SH (2004). Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 73, 437–465.[CrossRef][Medline]

Putney JW Jr & Bird GS (1993). The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr Rev 14, 610–631.[CrossRef][Medline]

Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA & Pozzan T (1998). Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280, 1763–1766.[Abstract/Free Full Text]

Villalobos C, Nuñez L, Montero M, García AG, Alonso MT, Chamero P, Alvarez J & García-Sancho J (2002). Redistribution of Ca2+ among cytosol and organella during stimulation of bovine chromaffin cells. FASEB J 16, 343–353.[Abstract/Free Full Text]

Werth JL & Thayer SA (1994). Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 14, 346–356.

White RJ & Reynolds IJ (1997). Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurons. J Physiol 498, 31–47.[Medline]


   Acknowledgements
 
This work was supported by grants from Ministerio de Educación y Ciencia (BFU2005-05464), from Junta de Castilla y León (VA016A05) and from Fondo de Investigaciones Sanitarias (PI040789). J.S. and E.H.-S. hold research personnel training (FPI) and University personnel training (FPU) fellowships, respectively, from the Spanish Ministerio de Educación y Ciencia. L.V. holds a fellowship from Fondo de Investigaciones Sanitarias (Spanish Ministerio de Sanidad). We thank Elena González for excellent technical assistance.




This article has been cited by other articles:


Home page
 BloodHome page
S.-R. A. Hussain, D. M. Lucas, A. J. Johnson, T. S. Lin, A. P. Bakaletz, V. X. Dang, S. Viatchenko-Karpinski, A. S. Ruppert, J. C. Byrd, P. Kuppusamy, et al.
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium
Blood, March 15, 2008; 111(6): 3190 - 3199.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
580/1/39    most recent
jphysiol.2006.126391v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vay, L.
Right arrow Articles by Alvarez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vay, L.
Right arrow Articles by Alvarez, J.
Related Collections
Right arrow Cellular

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS